HOME >> BIOLOGY >> NEWS
University Of Washington Discovery May Point The Way To New Treatment For Hepatitis C Cases That Do Not Respond To Interferon Therapy

Researchers at the University of Washington report in the April 14, 1997 issue of Virology that they may have an explanation for why the currently approved drug treatment for hepatitis C is ineffective much of the time. The drug, recombinant alpha interferon, is ineffective in 60 to 80 percent of cases.

"This discovery explains the molecular mechanisms for interferon resistance, and points the way to a potential new target for therapeutic drugs to treat hepatitis C," said the principal investigator, Dr. Michael G. Katze (kates), UW professor of microbiology and associate director of the UW's Regional Primate Research Center.

The UW's Office of Technology Transfer has negotiated a patent-based licensing agreement with RiboGene, Inc., a privately-held biotechnology company in Hayward, Calif., which will begin investigating drug therapies based on the UW discovery. Katze is a member of the company's scientific advisory board.

Hepatitis C (formerly called non-A, non-B hepatitis), caused by the virus, affects more than 3.5 million Americans. It is the major reason for liver failure necessitating liver transplants.

"Many viruses that affect humans -- hepatitis, influenza, herpes, HIV, polio and a host of others -- have evolved mechanisms to resist the effects of interferon, one of the body's first lines of defense against viruses," said Dr. Michael Gale, Jr., UW microbiology fellow who is lead scientist and first author of the study. The drug interferon is an artificial version of naturally-occurring interferon, a protein secreted by cells that "interferes with" viral infection and other challenges.

Earlier studies in Japan showed that interferon-resistant HCV strains have a specific RNA sequence within a region of the virus called NS5A. The UW researchers followed up on this research, and tested the ability of NS5A to interact with a key component of interferon response called PKR, a member of an important famil
'"/>

Contact: Laurie McHale
lmchale@u.washington.edu
206-543-3620
University of Washington
15-Apr-1997


Page: 1 2 3

Related biology news :

1. Indiana University, EPA to study airborne PCBs
2. University of Alberta researcher looks for clues to mysterious disease
3. Northeastern University receives $12.4 million NSF grant for creation of nanomanufacturing institute
4. Washington University in St. Louis leads group studying aging process
5. Tufts University establishes $4 million dollar tissue engineering resource center
6. Case for IBD combination therapy comes from research at Baylor, MIT and Hebrew University
7. As informatics grows, Indiana University helps set research agenda
8. University of Arizona licenses patent for natural fungicide
9. Washington University in St. Louis plays key role in sequencing moss genome
10. University of Pittsburgh receives $10 million grant for head and neck cancer
11. Clemson University spin-off uses corn to make plastics, provide cleaner air

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/28/2020)... ... , ... In an upcoming episode scheduled for the fall of 2020, Advancements ... (POCT). Check local listings for more info. , Today, the majority of testing is ... labs throughout the country. Results are then available several days later. Now, in an ...
(Date:6/23/2020)... (PRWEB) , ... June 23, 2020 , ... ... instrumentation, is pleased to announce the next event in a series of TOPIQ ... , The TOPIQ series of webinars was developed in response to social distancing ...
(Date:6/13/2020)... , ... June 11, 2020 , ... ... services, announces a significant expansion of its forensic genealogy team. Bode’s Forensic ... attorneys through proven forensic genealogy and DNA analysis methods. The team has added ...
Breaking Biology News(10 mins):
(Date:7/18/2020)... ... July 16, 2020 , ... ... aid in the early detection and prevention of high-burden diseases, and Centric Consulting, ... hospitals and healthcare organizations to utilize existing data in order to identify and ...
(Date:7/10/2020)... , ... July 09, 2020 , ... ... 1-phenyl-2-thiourea (PTU) is commonly used to suppress pigment formation in zebrafish embryos, maintaining ... research team led by Dr MA has been using the zebrafish model to ...
(Date:7/1/2020)... ... 29, 2020 , ... MedShift , a leading medical ... many obstacles created as a result of COVID-19. As a provider at the ... practices and medical manufacturers by expanding access to device offerings, technology services, and ...
(Date:6/28/2020)... ... June 25, 2020 , ... ... to develop a vaccine or drug treatment. In an effort to better understand ... publicly released the world’s largest imaging dataset portraying therapeutic compound effects from over ...
Breaking Biology Technology:
Cached News: